In addition to significant funding rounds this week for employee behavior measurement company VoloMetrix, Amazon Web Services partner 2nd Watch, and solar energy developer OneEnergy Renewables, we’re noting developments from Seattle-area companies large (Costco and Alibaba) and small... Read more »
Colorado telecom Zayo Group Holdings is now a public, $5 billion company, thanks to a massive IPO the Boulder-based company pulled off on Friday morning.
Zayo (NYSE: ZAYO) initially priced the deal below its expectations—it sold shares to investors at... Read more »
Entrepreneurs, bosses, and leaders are often highly social and extroverted—take Steve Jobs or Richard Branson. They can work a room. They derive energy from being around others.
But what if being outgoing and extroverted isn’t actually the key to success in... Read more »
For folks who fear nodding off on the job or during class, the team at Blanc believes their smartwatch can solve the problem.
At last night’s Getgeeked gadget show in New York, CEO Eddy Zhong, a 17-year-old high schooler, showed off... Read more »
From big venture firms to tiny genomics startups, we’ve got plenty to round up this week—beyond biotech, too, as the San Francisco Giants head east to the biggest baseball rodeo for the third time in five years, thanks to Seattle native... Read more »
Venture capital activity is down from a 13-year high during the second quarter, but a new MoneyTree Report released today shows that venture funding was still going strong in the three months that ended Sept. 30, with $9.9 billion invested in... Read more »
The Minerva Project, a San Francisco-based for-profit that aims to provide an Ivy League-caliber college degree for $10,000 a year, says it has closed on the bulk of a $70 million Series B round that will allow it to scale up... Read more »
Chimerix (NASDAQ: CMRX) is cleared to start a clinical trial studying its antiviral drug brincidofovir in patients infected with Ebola.
The Durham, NC, company announced today that the Food and Drug Administration gave the green light to test the compound... Read more »
Atara Biotherapeutics took a fairly unusual route to the Nasdaq. The Brisbane, CA-based company looked all set to price an IPO in July before abruptly yanking the offering, reportedly due to pending data on one of its drugs. After a small... Read more »
MyHealthDirect, a healthcare scheduling software company founded nine years ago in the Milwaukee area, has raised $8 million to help it expand—but it’s unclear how much of that will involve the local office.
MyHealthDirect’s registered business address is still in Brookfield,... Read more »